Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/effect-of-catheter-ablation-vs-medical-therapy-on-quality-of-life-SAdjErLAUm
References (45)
-
A. Wokhlu, K. Monahan, D. Hodge, S. Asirvatham, P. Friedman, T. Munger, D. Bradley, Christine Bluhm, Janis Haroldson, D. Packer (2010)
Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.Journal of the American College of Cardiology, 55 21
-
Gordon Guyatt, E. Juniper, S. Walter, Lauren Griffith, R. Goldstein (1998)
Interpreting treatment effects in randomised trialsBMJ, 316
-
D. Packer, D. Mark, R. Robb, K. Monahan, T. Bahnson, J. Poole, P. Noseworthy, Y. Rosenberg, N. Jeffries, L. Mitchell, G. Flaker, E. Pokushalov, A. Romanov, T. Bunch, G. Noelker, A. Ardashev, A. Revishvili, D. Wilber, R. Cappato, K. Kuck, G. Hindricks, D. Davies, P. Kowey, G. Naccarelli, J. Reiffel, J. Piccini, A. Silverstein, H. Al-Khalidi, Kerry Lee (2019)
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialJAMA, 321
-
C. Morillo, A. Verma, S. Connolly, K. Kuck, G. Nair, J. Champagne, L. Sterns, H. Beresh, J. Healey, A. Natale (2014)
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.JAMA, 311 7
-
Mark (2016)
1048JAMA Cardiol, 1
-
Hlatky (1989)
651Am J Cardiol, 64
-
Dajuanicia Simon, L. Thomas, Emily O'Brien, G. Fonarow, B. Gersh, P. Kowey, J. Reiffel, G. Naccarelli, J. Spertus, E. Peterson, J. Piccini (2016)
Abstract 130: Clinically Important Difference in the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Score: Results from the ORBIT-AF RegistryCirculation-cardiovascular Quality and Outcomes, 9
-
C. Pappone, G. Augello, S. Sala, F. Gugliotta, G. Vicedomini, S. Gulletta, G. Paglino, P. Mazzone, N. Sora, I. Greiss, Andreina Santagostino, L. Livolsi, N. Pappone, A. Radinovic, F. Manguso, V. Santinelli (2006)
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.Journal of the American College of Cardiology, 48 11
-
D. Mark, Kerry Lee, F. Harrell (2016)
Understanding the Role of P Values and Hypothesis Tests in Clinical Research.JAMA cardiology, 1 9
-
Wokhlu (2010)
2308J Am Coll Cardiol, 55
-
D. Packer, D. Mark, R. Robb, K. Monahan, T. Bahnson, Kathleen Moretz, J. Poole, A. Mascette, Y. Rosenberg, N. Jeffries, H. Al-Khalidi, Kerry Lee (2018)
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and DesignAmerican heart journal, 199
-
Wilber (2010)
333JAMA, 303
-
A. Kasuya (1990)
EuroQol--a new facility for the measurement of health-related quality of life.Health policy, 16 3
-
Pappone (2006)
2340J Am Coll Cardiol, 48
-
D. Wilber, C. Pappone, P. Neužil, Â. Paola, F. Marchlinski, A. Natale, L. Macle, E. Daoud, H. Calkins, Burr Hall, V. Reddy, G. Augello, M. Reynolds, Chandan Vinekar, Christopher Liu, S. Berry, D. Berry (2010)
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.JAMA, 303 4
-
Bubien (1996)
1585Circulation, 94
-
Coon (2016)
22Ther Innov Regul Sci, 50
-
Guyatt (1998)
690BMJ, 316
-
Koopman (2002)
14J Occup Environ Med, 44
-
Morillo (2014)
692JAMA, 311
-
Pierre Jai¨s, Michel Hai¨ssaguerre, D. Shah, S. Chouairi, L. Gencel, M. Hocini, Jacques Cle´menty (1997)
A focal source of atrial fibrillation treated by discrete radiofrequency ablation.Circulation, 95 3
-
Haïssaguerre (1994)
1045J Cardiovasc Electrophysiol, 5
-
Cosedis Nielsen (2012)
1587N Engl J Med, 367
-
J. Nielsen, A. Johannessen, P. Raatikainen, G. Hindricks, H. Walfridsson, O. Kongstad, S. Pehrson, A. Englund, J. Hartikainen, L. Mortensen, P. Hansen (2012)
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.The New England journal of medicine, 367 17
-
Oral (2006)
934N Engl J Med, 354
-
J. Spertus, P. Dorian, R. Bubien, S. Lewis, Donna Godejohn, M. Reynolds, D. Lakkireddy, A. Wimmer, A. Bhandari, C. Burk (2011)
Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 4
-
P. Dorian, M. Paquette, D. Newman, M. Green, S. Connolly, M. Talajic, D. Roy (2002)
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.American heart journal, 143 6
-
C. Koopman, K. Pelletier, J. Murray, C. Sharda, M. Berger, R. Turpin, Paul Hackleman, Pamela Gibson, D. Holmes, Talor Bendel (2002)
Stanford Presenteeism Scale: Health Status and Employee ProductivityJournal of Occupational and Environmental Medicine, 44
-
M. Reilly, A. Zbrozek, E. Dukes (1993)
The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 4
-
Wazni (2005)
2634JAMA, 293
-
Reilly (1993)
353Pharmacoeconomics, 4
-
Simon (2018)
A130Circ Cardiovasc Qual Outcomes, 9
-
C. Coon, J. Cappelleri (2016)
Interpreting Change in Scores on Patient-Reported Outcome InstrumentsTherapeutic Innovation & Regulatory Science, 50
-
M. Haïssaguerre, L. Gencel, B. Fischer, P. Métayer, F. Poquet, F. Marcus, J. Clémenty (1994)
Successful Catheter Ablation of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 5
-
M. Hlatky, R. Boineau, M. Higginbotham, Kerry Lee, D. Mark, R. Califf, F. Cobb, D. Pryor (1989)
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index).The American journal of cardiology, 64 10
-
H. Oral, C. Pappone, A. Chugh, Eric Good, F. Bogun, F. Pelosi, E. Bates, M. Lehmann, G. Vicedomini, G. Augello, E. Agricola, S. Sala, V. Santinelli, F. Morady (2006)
Circumferential pulmonary-vein ablation for chronic atrial fibrillation.The New England journal of medicine, 354 9
-
R. Bubien, S. Knotts-Dolson, V. Plumb, G. Kay (1996)
Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.Circulation, 94 7
-
D. Mark (2016)
Assessing quality-of-life outcomes in cardiovascular clinical researchNature Reviews Cardiology, 13
-
Mark (2016)
286Nat Rev Cardiol, 13
-
Dorian (2002)
984Am Heart J, 143
-
Packer (2018)
192Am Heart J, 199
-
Jaïs (1997)
572Circulation, 95
-
O. Wazni, N. Marrouche, David Martin, A. Verma, M. Bhargava, W. Saliba, Dianna Bash, R. Schweikert, J. Brachmann, J. Gunther, K. Gutleben, E. Pisanò, D. Potenza, R. Fanelli, A. Raviele, S. Themistoclakis, A. Rossillo, A. Bonso, A. Natale (2005)
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.JAMA, 293 21
-
Spertus (2011)
15Circ Arrhythm Electrophysiol, 4
-
EuroQol Group (1990)
199Health Policy, 16
- Publisher
- American Medical Association
- Copyright
- Copyright 2019 American Medical Association. All Rights Reserved.
- ISSN
- 0098-7484
- eISSN
- 1538-3598
- DOI
- 10.1001/jama.2019.0692
- Publisher site
- See Article on Publisher Site
Abstract
Key PointsQuestionWhat is the effect of catheter ablation, compared with medical therapy, on quality of life in patients with symptomatic atrial fibrillation? FindingsIn this randomized trial of 2204 patients with atrial fibrillation, catheter ablation, compared with conventional medical therapy, significantly improved quality of life at 1 year as measured by the Atrial Fibrillation Effect on Quality of Life score (mean between-group difference, 5.2 points; patient-level clinically important difference, ≥5 points) and the Mayo AF-Specific Symptom Inventory frequency score (mean between-group difference, −1.7 points; patient-level clinically important difference, ≤−1.6 points) and severity score (mean between-group difference, −1.5 points; patient-level clinically important difference, ≤−1.3 points). MeaningIn patients with symptomatic atrial fibrillation, catheter ablation, compared with medical therapy, led to clinically important and significant improvements in quality of life at 12 months.
Journal
JAMA – American Medical Association
Published: Apr 2, 2019